Safety and Efficacy of Apixaban in HeartMate 3 Left Ventricular Assist Devices

In patients with HM3 LVADs, apixaban may be a safe and clinically effective alternative to warfarin.

Authors

Institutions

Publication Details

Journal
Clinical Transplantation
Published
2026-01-01
DOI
https://doi.org/10.1111/ctr.70430
Primary Topic
Mechanical Circulatory Support Devices
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Safety and Efficacy of Apixaban in HeartMate 3 Left Ventricular Assist Devices

Ashwin Pillai, Amanda Maxfield, Jason Gluck, Balaphanidhar Mogga et al.
Clinical Transplantation
Mechanical Circulatory Support Devices
article

Safety and Efficacy of Apixaban in HeartMate 3 Left Ventricular Assist Devices

Ashwin Pillai, Amanda Maxfield, Jason Gluck, Balaphanidhar Mogga, Dawn Surprenant, Kelly McNamara‐Diorio, Cesar Rubio‐Ramos, Aryan Mehta, Abhishek Jaiswal, Katrina F. Etts
article en

Abstract

In patients with HM3 LVADs, apixaban may be a safe and clinically effective alternative to warfarin.

Clinical TransplantationVol. 40(1)
Hartford Hospital (US), University of Connecticut (US), UConn Health (US)
Openalex Percentile: Top 96%
Mechanical Circulatory Support Devices
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.